News Aflibercept May Be Effective for Resistant Exudative AMD by Medscape • 2017/06/14 • 0 Comments Aflibercept appears to improve outcomes in patients with exudative age-related macular degeneration (AMD) resistant to treatment with ranibizumab or bevacizumab, researchers from Norway report. Reuters Health Information Full Story →